跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BE-4-4-4-4
首页
药物
BE-4-4-4-4
BE-4-4-4-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Metabolically Engineered Cells for the Production of Resveratrol or an Oligomeric or Glycosidically-Bound Derivative Thereof
US 2008286844 A1
申请人: FLUXOME SCIENCES AS
优先权: 2005
CN
EP
US
WO
11 件公开
COCRYSTAL OF PHOSPHORIC ACID AND A MC1R AGONSIST
EP 3903785 B1
申请人: MITSUBISHI TANABE PHARMA CORP
优先权: 2018
CN
EP
US
WO
11 件公开
7-BENZYL-4-(4-(TRIFLUOROMETHYL)BENZYL)-1,2,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(4H)-ONE AND SALTS THEREOF AND THEIR USE IN THERAPY
EP 3250208 B1
申请人: ONCOCEUTICS INC
优先权: 2015
CN
EP
US
7 件公开
AGENT FOR OVERCOMING RESISTANCE TO ANTI-CANCER AGENT
EP 3219319 A1
申请人: NIPPON CHEMIPHAR CO
优先权: 2006
CN
EP
US
5 件公开
ANALOGUES OF AZABICYCLIC COMPOUNDS
EP 4538257 A4
申请人: TAIHO PHARMACEUTICAL CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof
US 7674915 B2
申请人: AJINOMOTO KK
优先权: 2003
US
4 件公开
PROCESS FOR PREPARATION OF SUBSTITUTED N-(2-CHLOROETHYL)-N´-HYDROXY-3-PHENOXYPYRIDAZINE-3- CARBOXAMIDINES AND SUBSTITUTED 3-(3-PHENOXYPYRIDAZIN-4-YL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINES
EP 4801893 A1
申请人: BAYER AG
优先权: 2023
CN
EP
WO
3 件公开
1,2,4-thiadiazole compounds and use thereof
US 7361675 B2
申请人: SUMITOMO CHEMICAL CO
优先权: 2002
CN
US
3 件公开
Method for the separation of intermediates which may be used for the preparation of escitalopram
US 7582780 B2
申请人: LUNDBECK & CO AS H
优先权: 2005
CN
US
3 件公开
Quinoline derivatives for modulating DNA methylation
US 7939546 B2
申请人: SUPERGEN INC
优先权: 2009
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈